Kenneth B. Lee, Jr., MBA

Treasurer

Kenneth B. Lee, Jr., MBA, is a general partner of Hatteras Ventures Partners, LLC, a venture capital fund focusing on life science companies. Ken is the former co-head of the International Life Sciences Practice for Ernst & Young, where he established a career over 29 years advising biotechnology and pharmaceutical companies throughout the world.

He got his start in biotech as part of the first audit team of Genentech in 1976. As co-founder and manager of the EY’s national life sciences practice from his location in the San Francisco Bay Area, he advised numerous high profile life science companies with their initial public offerings, mergers and acquisitions, and strategic financings. Among others, these firms included: Affymax, Affymetrix, Applied ImmuneSciences, Chiron, Circadian, Genentech, Heartport, Systemix, ALZA, and Collagen.

Ken has served on the Board of Directors of 10 publicly held life sciences companies, including CV Therapeutics, Abgenix, Maxygen, OSI, Inspire Pharmaceuticals, and Biocryst, among others. He also served on the boards of several privately-held life sciences companies.

Ken served as CFO and interim CEO of the CEO Roundtable on Cancer, a not-for-profit organization founded by George H. W. Bush, Dr. Martin J. Murphy, and Robert Ingram. He also served on the Boards of the UNC Health Foundation and of NCBIO.

Ken graduated with a BA from Lenoir-Rhyne College and has an MBA from the University of North Carolina at Chapel Hill.